Clinical Trial Update: hCAP18 Levels and Vitamin D Deficiency in Chronic Kidney Disease [NA]

View source ↗

Summary

The Massachusetts General Hospital-sponsored trial evaluating hCAP18 levels and vitamin D deficiency in chronic kidney disease has been withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chronic Kidney Disease
• Vitamin Deficiency

Snippet

Sponsor: Massachusetts General Hospital | Conditions: Chronic Kidney Disease, Vitamin D Deficiency | NA | Status: WITHDRAWN